Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Buys 168,894 Shares of Company Stock

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Shahar Ben-Noon acquired 168,894 shares of the stock in a transaction on Monday, September 28th. The stock was purchased at an average cost of $0.71 per share, with a total value of $119,914.74. Following the transaction, the chief executive officer directly owned 3,646,133 shares of the company’s stock, valued at $2,588,754.43. This represents a 4.86% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Inspira Technologies OXY B.H.N. Trading Down 2.0%

Shares of NASDAQ QTEX traded down $0.01 during trading on Tuesday, reaching $0.67. 4,356,021 shares of the stock were exchanged, compared to its average volume of 10,831,636. The business’s 50-day moving average price is $0.89. Inspira Technologies OXY B.H.N. Ltd has a twelve month low of $0.28 and a twelve month high of $3.85. The company has a current ratio of 2.00, a quick ratio of 1.62 and a debt-to-equity ratio of 0.12.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last released its quarterly earnings results on Thursday, September 24th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has approved a share repurchase plan on Monday, June 22nd that allows the company to repurchase 2,000,000,000,000 shares. This repurchase authorization allows the company to reacquire up to 5.6% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on QTEX. Weiss Ratings upgraded Inspira Technologies OXY B.H.N. from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Friday. Wall Street Zen downgraded shares of Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a research report on Saturday, August 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies OXY B.H.N. Ltd. is an Israeli medical technology company focused on developing advanced respiratory-support systems for patients experiencing acute respiratory failure. The company’s technology is intended to support blood oxygenation and carbon-dioxide removal while potentially reducing reliance on invasive mechanical ventilation.

Its principal product platform is the INSPIRA ART system, an extracorporeal respiratory-support technology designed to oxygenate blood outside the body and return it to the patient.